Leader in developing frontier biology and frontier AI to solve "holy grail" challenges in biology. Former co-head of Growth Equity at Generation Investment Management. Computational Biology (Cambridge), Mathematics (Dartmouth).
Leads the Blundell Lab (Early Cancer Institute, Cambridge). Pioneer in quantitative cancer evolution. "Understanding recognition is understanding the first principle of biology".
Former Microsoft Research. Led breakthrough work in biological computation. "We're turning biology's hardest problem into a software problem".
Led target ID and development of Immunocore’s KIMMTRAK, the first approved TCR therapy.
Theoretical physicist turned AI scientist.
Drug Discovery AI Researcher.
Former lead of Microsoft Research wet lab. Creative assay developer for high throughput data generation.
Former UI Path. Extensive experience in reinforcement learning, generative modeling and large language models. Building Synteny's agentic layer for scientific exploration.
Lewis Cornwall, Senior AI Scientist
James Day, Head of Engineering
Guy Durant, AI Research Scientist
Lisa Hinton, Chief of Staff
Dubravka Pezic Kessler, Principal Scientist
James King, AI Research Scientist
S R Gokul Krishnan, Engineer
Victoria Koullourou, Senior Scientist
Somayya Manzoor, Senior Scientist
Anton Shmelev, Senior Scientist
Experimental Abundance
High diversity, massive-scale, domain-specific data. We generate ground truth at the unprecedented scale required for performant AI.
Learn Life’s Language
We're not limited by samples and examples — we're discovering the rules that govern all molecular recognition.
Design-Led Development
Every molecule is precisely designed to solve a translational need, at speed never before possible.
We are seeking radically talented, passionate and ambitious people to join our mission to tackle biology’s grand challenges. If you are a student of your craft, driven by insatiable curiosity and the will to bring new ideas to formerly intractable problems, please reach out: future@synteny.ai
Headquartered in the UK, thinking globally. Our flagship location in the UK, with presence in the US and Zurich, provides access to world-class talent, embedded in leading biotech ecosystems.
We are entering the era where the intersection of biology, mathematics and computer science divines new solutions to grand challenges in human disease.
Synteny is creating the methods to understand disease at its most fundamental level — and to intervene with precision.
When we decode molecular recognition, we unlock a future where the algorithm becomes the drug, where every disease has a designed solution, where previously impossible medicines become inevitable.
